Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bashir

Showing results (291-300 of 364) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|November 16, 2019
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen A Harrison, Mustafa R Bashir, Cynthia D Guy, et al.
Gastroenterology|November 17, 2018
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic ReviewChristian B van der Pol, Christopher S Lim, Claude B Sirlin, et al.
Cancers|June 2, 2021
Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation StudyJingwei Wei, Hanyu Jiang, Mengsu Zeng, et al.
Radiology|January 14, 2025
Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual ImagingBenjamin Wildman-Tobriner, Nicholas Felice, Kevin R Kalisz, et al.
Alimentary Pharmacology & Therapeutics|October 3, 2023
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitisStephen A Harrison, Vlad Ratziu, Quentin M Anstee, et al.
Radiology|February 10, 2026
Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with CirrhosisSara Lewis, Benjamin Wildman-Tobriner, Jordan Cuevas, et al.
Human Molecular Genetics|April 10, 1999
Dysferlin is a plasma membrane protein and is expressed early in human developmentL V Anderson, K Davison, J A Moss, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 14, 2019
An update for LI-RADS: Version 2018. Why so soon after version 2017?Ania Z Kielar, Victoria Chernyak, Mustafa R Bashir, et al.
European Radiology|July 19, 2024
Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resectionHong Wei, Tianying Zheng, Xiaolan Zhang, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 25, 2022
Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical PracticeKathryn J Fowler, Mustafa R Bashir, David T Fetzer, et al.
Pageof 37

Showing results (291-300 of 364) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|November 16, 2019
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen A Harrison, Mustafa R Bashir, Cynthia D Guy, et al.
Gastroenterology|November 17, 2018
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic ReviewChristian B van der Pol, Christopher S Lim, Claude B Sirlin, et al.
Cancers|June 2, 2021
Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation StudyJingwei Wei, Hanyu Jiang, Mengsu Zeng, et al.
Radiology|January 14, 2025
Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual ImagingBenjamin Wildman-Tobriner, Nicholas Felice, Kevin R Kalisz, et al.
Alimentary Pharmacology & Therapeutics|October 3, 2023
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitisStephen A Harrison, Vlad Ratziu, Quentin M Anstee, et al.
Radiology|February 10, 2026
Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with CirrhosisSara Lewis, Benjamin Wildman-Tobriner, Jordan Cuevas, et al.
Human Molecular Genetics|April 10, 1999
Dysferlin is a plasma membrane protein and is expressed early in human developmentL V Anderson, K Davison, J A Moss, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 14, 2019
An update for LI-RADS: Version 2018. Why so soon after version 2017?Ania Z Kielar, Victoria Chernyak, Mustafa R Bashir, et al.
European Radiology|July 19, 2024
Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resectionHong Wei, Tianying Zheng, Xiaolan Zhang, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 25, 2022
Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical PracticeKathryn J Fowler, Mustafa R Bashir, David T Fetzer, et al.
Pageof 37